Shravan Ambati, MD
Clinical Cardiac Electrophysiology · Orlando, FLNPI 1104985290
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 50 manufacturers reported payments, led by Boehringer Ingelheim at 24.2% of the total. Reporting peaked in 2024 at $43,085 and has fallen 53.1% since, to $20,226 in 2025. Among clinical cardiac electrophysiology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 777 payments — averaging $207.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$39K
- Biotronik Inc.$28K
- Abbott$22K
- Angiodynamics, Inc.$19K
- E.r. Squibb & Sons, L.L.C.$15K
- Novartis$8K
- plus $31K from 44 others
Across 189 payments — averaging $1083.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Esperion Therapeutics, Inc.$171K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$29K
- Kowa Research Institute, Inc.$5K
What the payments were for
- Consulting fees$32,80220%
- Speaking & faculty fees$67,59542%
- Travel & lodging$15,1159%
- Food & beverage$26,78017%
- Education$490%
- Entertainment$2230%
- Other$18,74512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$45,529
- Auryon Atherectomy Catheter 1.5 mm OTW$18,745
- ELIQUIS$16,534
- Edora$8,319
- ENTRESTO$7,056
- ACCENT$6,400
- Rivacor$6,319
- Acticor$6,319
- Sentus$4,095
- Plexa$3,746
- Acticor 7 VR-T DX$3,705
- BioMonitor$3,495
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$2,791
- Farapulse$2,787
- Solia$2,713
- GALLANT$1,957
- Accent Pacemaker$1,850
- AVEIR$1,649
- Arctic Front$1,629
- Sotalol Hydrochloride$1,622
How this compares
$161,309 in reported general payments places this provider in the 90th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 499 | $612,484 |
| JardianceEmpagliflozin | 348 | $405,525 |
| EntrestoSacubitril/Valsartan | 212 | $278,642 |
| XareltoRivaroxaban | 76 | $79,512 |
| FarxigaDapagliflozin Propanediol | 52 | $53,763 |
| OzempicSemaglutide | 44 | $51,369 |
| BrilintaTicagrelor | 73 | $48,903 |
| Amiodarone Hcl | 226 | $8,945 |
| Repatha SyringeEvolocumab | 14 | $8,722 |
| Metoprolol Succinate | 507 | $6,783 |
| Ranolazine ErRanolazine | 30 | $6,681 |
| Midodrine Hcl | 46 | $5,898 |
| ClopidogrelClopidogrel Bisulfate | 438 | $5,039 |
| Atorvastatin Calcium | 467 | $4,046 |
| SotalolSotalol Hcl | 141 | $3,892 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $2,456 | $612,484499 claims |
| Boehringer IngelheimJardiance | $38,979 | $405,525348 claims |
| NovartisEntresto | $7,827 | $278,642212 claims |
| AstraZenecaFarxiga, Brilinta | $492 | $102,666125 claims |
| Johnson & JohnsonXarelto | $290 | $79,51276 claims |
| Novo NordiskOzempic | $409 | $51,36944 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Orlando
- George MonirOrlando$70K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.